The Human Medicines Regulations 2012
10 Exceptions to requirement for marketing authorisation etc
- 167Supply to fulfil special patient needs
- 167aNIMAR supply to Northern Ireland
- 167bList of NIMAR products
- 167cEarly Access to Medicines Scheme: establishment and licensing authority functions
- 167dEAMS scientific opinions ceasing to have effect
- 167eEAMS medicinal products: manufacture, assembly, importation, distribution and supply
- 167fAdvertising of EAMS medicinal products
- 167gEAMS medicinal products: pharmacovigilance
- 167hEarly Access to Medicines Scheme: data collection
- 168Use of non-prescription medicines in the course of a business
- 169Mixing of general sale medicinal products
- 170Record-keeping requirements
- 170aMM medicinal products: pharmacovigilance requirements
- 170bPOC medicinal products: pharmacovigilance requirements
- 171Exempt advanced therapy medicinal products
- 172Parallel import licences
- 173Exemption for certain radiopharmaceuticals
- 174Supply in response to spread of pathogenic agents etc
- 174aConditions of temporary authorisations under regulation 174
Source: legislation.gov.uk (The National Archives), UK legislation with its point-in-time versions. Official publication. Reuse: Open Government Licence v3.0.